These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38949624)

  • 1. Contribution of Phe112, Ser114, and Tyr115 to Drug-Binding Selectivity in the A Variant of α
    Nakamura Y; Watanabe H; Nakamura T; Chirifu M; Ishiodori K; Imafuku T; Maeda H; Kobashigawa Y; Morioka H; Maruyama T
    Mol Pharm; 2024 Aug; 21(8):4038-4046. PubMed ID: 38949624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the α
    Nakamura Y; Watanabe H; Imafuku T; Fujita I; Ganaha Y; Takeo T; Nakagata N; Maeda H; Maruyama T
    Mol Pharm; 2024 Jul; 21(7):3144-3150. PubMed ID: 38862418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of biantennary glycans and genetic variants of human alpha1-acid glycoprotein in enantioselective binding of basic drugs as studied by high performance frontal analysis/capillary electrophoresis.
    Kuroda Y; Kita Y; Shibukawa A; Nakagawa T
    Pharm Res; 2001 Mar; 18(3):389-93. PubMed ID: 11442281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A site-directed mutagenesis study of drug-binding selectivity in genetic variants of human alpha(1)-acid glycoprotein.
    Nishi K; Ueno M; Murakami Y; Fukunaga N; Akuta T; Kadowaki D; Watanabe H; Suenaga A; Maruyama T; Otagiri M
    J Pharm Sci; 2009 Nov; 98(11):4316-26. PubMed ID: 19198000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insights into differences in drug-binding selectivity between two forms of human alpha1-acid glycoprotein genetic variants, the A and F1*S forms.
    Nishi K; Ono T; Nakamura T; Fukunaga N; Izumi M; Watanabe H; Suenaga A; Maruyama T; Yamagata Y; Curry S; Otagiri M
    J Biol Chem; 2011 Apr; 286(16):14427-34. PubMed ID: 21349832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilicity Influences Drug Binding to α1-Acid Glycoprotein F1/S Variants But Not to the A Variant.
    Hanada K
    Drugs R D; 2017 Sep; 17(3):475-480. PubMed ID: 28646384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of selective competitive binding of basic drugs to alpha1-acid glycoprotein variants.
    Ishizaki J; Fukaishi A; Fukuwa C; Yamazaki S; Tabata M; Ishida T; Suga Y; Arai K; Yokogawa K; Miyamoto K
    Biol Pharm Bull; 2010; 33(1):95-9. PubMed ID: 20045943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary electrophoretic study on pH dependence of enantioselective disopyramide binding to genetic variants of human alpha1-acid glycoprotein.
    Kuroda Y; Matsumoto S; Shibukawa A; Nakagawa T
    Analyst; 2003 Aug; 128(8):1023-7. PubMed ID: 12964601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantioselective binding of disopyramide to alpha1-acid glycoprotein and its variants.
    Kishino S; Itoh S; Nakagawa T; Miyazaki K
    Eur J Clin Pharmacol; 2001 Oct; 57(8):583-7. PubMed ID: 11758636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrolase Activity of the Genetic Variants of Human Alpha-1-Acid Glycoprotein.
    Kono K; Fujimura R; Nakamura Y; Matsuura K; Nunoya KI; Yamaura Y; Imawaka H; Watanabe H; Maruyama T
    Mol Pharm; 2022 Mar; 19(3):798-804. PubMed ID: 35179021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug binding analysis of human alpha 1-acid glycoprotein using capillary electrophoresis].
    Kuroda Y; Shibukawa A; Nakagawa T
    Yakugaku Zasshi; 2003 Sep; 123(9):781-8. PubMed ID: 14513769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic variant A of human alpha 1-acid glycoprotein limits the blood to brain transfer of drugs it binds.
    Jolliet-Riant P; Boukef MF; Duché JC; Simon N; Tillement JP
    Life Sci; 1998; 62(14):PL219-26. PubMed ID: 9570346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformation selectivity in the binding of diazepam and analogues to alpha1-acid glycoprotein.
    Fitos I; Visy J; Zsila F; Mády G; Simonyi M
    Bioorg Med Chem; 2007 Jul; 15(14):4857-62. PubMed ID: 17507228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective binding of tamsulosin to genetic variants of human alpha1-acid glycoprotein.
    Hanada K; Tochikura N; Ogata H
    Biol Pharm Bull; 2007 Aug; 30(8):1593-5. PubMed ID: 17666829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of disopyramide, methadone, dipyridamole, chlorpromazine, lignocaine and progesterone to the two main genetic variants of human alpha 1-acid glycoprotein: evidence for drug-binding differences between the variants and for the presence of two separate drug-binding sites on alpha 1-acid glycoprotein.
    Hervé F; Duché JC; d'Athis P; Marché C; Barré J; Tillement JP
    Pharmacogenetics; 1996 Oct; 6(5):403-15. PubMed ID: 8946472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-binding energetics of human α-1-acid glycoprotein assessed by isothermal titration calorimetry and molecular docking simulations.
    Huang JX; Cooper MA; Baker MA; Azad MA; Nation RL; Li J; Velkov T
    J Mol Recognit; 2012 Dec; 25(12):642-56. PubMed ID: 23192962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective binding of imatinib to the genetic variants of human alpha1-acid glycoprotein.
    Fitos I; Visy J; Zsila F; Mády G; Simonyi M
    Biochim Biophys Acta; 2006 Nov; 1760(11):1704-12. PubMed ID: 17008009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biantennary glycans as well as genetic variants of alpha1-acid glycoprotein control the enantioselectivity and binding affinity of oxybutynin.
    Kimura T; Shibukawa A; Matsuzaki K
    Pharm Res; 2006 May; 23(5):1038-42. PubMed ID: 16715395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enantioselective binding of propranolol, disopyramide, and verapamil to human alpha(1)-acid glycoprotein.
    Hanada K; Ohta T; Hirai M; Arai M; Ogata H
    J Pharm Sci; 2000 Jun; 89(6):751-7. PubMed ID: 10824133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of alpha1-acid glycoprotein in inter-individual variation of disposition kinetics of ropivacaine following epidural infusion in off-pump coronary artery bypass grafting.
    Yokogawa K; Shimomura S; Ishizaki J; Shimada T; Fukuwa C; Kawada M; Tsubokawa T; Yamamoto K; Miyamoto K
    J Pharm Pharmacol; 2007 Jan; 59(1):67-73. PubMed ID: 17227622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.